Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain weight loss efficacy. Cengiz A, Wu CC, Lawley SD. Diabetes Obes Metab 2025;27:2251-2258.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cengiz A, Wu CC, Lawley SD. Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain weight loss efficacy. Diabetes Obes Metab 2025;27:2251-2258.
PMID: 39950222